← 產業報告目錄

Latin America Advanced Wound Care Market by Product (Foam, Hydrocolloid, Film, Alginate, Collagen), Wound Type (Chronic (Diabetic Foot Ulcers, Pressure Ulcers), Acute (Surgical, Burns)), End User (Hospitals, Clinics, ASCs), Region - Forecast to 2030

出版商 MarketsandMarkets產業別 Medical Devices出版日期 2025-04-23頁數 222報告編號 MD9354

授權報價

Single User Licence$4,950 USD
Multi User Licence$6,650 USD
Corporate User Licence$8,150 USD
Global User Licence$10,000 USD
洽詢購買 申請 Sample

報告摘要

The LATAM advanced wound care market is projected to reach USD 498.2 million by 2030 from USD 312.8 million in 2025, at a CAGR of 9.8% during the forecast period. The growth of the LATAM advanced wound care market is primarily driven by the rising incidence of chronic conditions that hinder wound healing, the growing geriatric population, and the emergence of age-related syndromes. The increasing prevalence of diabetes and obesity further accelerates this trend. Moreover, the surge in burn injuries, trauma cases, and road accidents has increased the demand for effective advanced wound care solutions. However, the high cost of advanced wound care products and the potential risks associated with their use pose challenges to market expansion. Despite these barriers, the ongoing development of healthcare infrastructure and the adoption of advanced technologies present substantial opportunities for market growth. By end user, the hospitals & clinics segment of the LATAM advanced wound care market accounted for the largest market share in 2024. Based on end users, the LATAM advanced wound care market is divided into hospitals & clinics, ambulatory surgery centers, home care settings, and other end users. In 2024, hospitals & clinics accounted for the largest share of the Latin American advanced wound care market due to their ability to manage a high volume of chronic and complex wound cases, such as diabetic foot ulcers, pressure ulcers, and venous leg ulcers, as well as their advanced infrastructure, availability of specialized care, and rising hospital admissions linked to chronic wounds and hospital-acquired infections. By application, the chronic wounds segment accounted for the largest market share of the LATAM advanced wound care market. The LATAM advanced wound care market is segmented into acute and chronic wounds. The chronic wounds segment accounted for the largest market share in 2024, primarily due to the rising number of traffic accidents, workplace injuries, and other trauma-related incidents requiring immediate medical care. The increasing number of surgical procedures for chronic wounds and the importance of treatments for peri-operative wounds are also expected to contribute to the market growth of this segment. The chronic wounds segment is further divided into diabetic foot ulcers, pressure ulcers, and other chronic wounds, each requiring specialized products for treatment. Diabetic foot ulcers and pressure ulcers are common & expensive, highlighting the critical nature of the market. Advanced wound care solutions are essential for managing chronic wounds, particularly for enhanced patient safety and efficient wound care procedures. By region, Mexico is expected to grow at the highest CAGR during the forecast period. The LATAM advanced wound care market is segmented into Brazil, Mexico, Argentina, Colombia, Peru, Chile, and the rest of Latin America. The market in Mexico is expected to grow at the highest CAGR during the forecast period, owing to the expansion of the geriatric population, the rising healthcare costs, and the increasing incidence of chronic wounds. Mexico is expected to grow at the highest CAGR of 11.8% during the forecast period. Additionally, the growing incidence of diabetes has led to a rise in diabetic foot ulcers, highlighting the significance of proper wound care. As wound care awareness improves and healthcare services advance, the demand for LATAM advanced wound care solutions in Mexico will contribute to market growth during the forecast period. A breakdown of the primary participants referred to for this report is provided below: • By Company Type: Tier 1−20%, Tier 2−45%, and Tier 3–35% • By Designation: C-level–30%, Director-level–20% and Others–50% • By Region: Brazil–35%, Mexico–25%, Argentina–10%, Chile- 8%, Colombia – 7%, Peru-5%, and the rest of Latin America–10% Note 1: Companies are classified into tiers based on their total revenue. As of 2024, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion. Note 2: C-level primaries include CEOs, CFOs, COOs, and VPs. Note 3: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers. The leading players operating in the LATAM advanced wound care market are Solventum (US), Smith+Nephew (UK), Cardinal Health (US), B. Braun SE (Germany), Mölnlycke AB (Sweden), Essity Aktiebolag (Sweden), Convatec Group PLC (UK), PAUL HARTMANN AG (Germany), Coloplast Group (Denmark), Integra LifeSciences Corporation (US), MATIV HOLDINGS, INC. (US), Owens & Minor (US), and AVERY DENNISON CORPORATION (US). Research Coverage This report studies the LATAM advanced wound care market based on product, wound type, end user, and country. The report also studies factors (such as drivers, restraints, opportunities, and challenges) affecting market growth and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets concerning their growth trends. It forecasts the revenue of the market segments relating to five major regions (and the respective countries in these regions). Reasons to Buy the Report The report will enable established and entrants/smaller firms to gauge the market's pulse, which, in turn, would help them gain a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence. This report provides insights into the following points: • Analysis of Key DROCs: Drivers (the increasing incidence of chronic conditions impairing wound healing, the rising incidence of burn injuries, the growing number of trauma cases and road accidents); restraints (high cost of advanced wound care products, risk associated with advanced wound care products); opportunities (expansion of healthcare infrastructure & uptake of advanced technologies and universal health coverage); and challenges (shortage of skilled healthcare professionals, complications associated with delayed diagnosis, and limited awareness) • Market Penetration: Comprehensive information on the product portfolios offered by the top players in the LATAM advanced wound care market • Product Development/Innovation: Detailed insights into the upcoming trends, R&D activities, and product launches in the LATAM advanced wound care market • Market Development: Comprehensive information on lucrative emerging regions • Market Diversification: Exhaustive information about new products, growing geographies, and recent developments in the LATAM advanced wound care market Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and products of the leading market players.
目錄 Table of Contents
1 INTRODUCTION 21 1.1 STUDY OBJECTIVES 21 1.2 MARKET DEFINITION 21 1.3 MARKET SCOPE 22 1.3.1 MARKET SEGMENTATION & REGIONAL SCOPE 22 1.3.2 INCLUSIONS & EXCLUSIONS 23 1.3.3 YEARS CONSIDERED 23 1.3.4 CURRENCY CONSIDERED 24 1.4 STAKEHOLDERS 24 2 RESEARCH METHODOLOGY 25 2.1 RESEARCH DATA 25 2.1.1 SECONDARY DATA 26 2.1.1.1 Key data from secondary sources 27 2.1.2 PRIMARY DATA 27 2.1.2.1 Primary sources 28 2.1.2.2 Key industry insights 29 2.1.2.3 Key data from primary sources 29 2.1.2.4 Breakdown of primary interviews 30 2.2 MARKET SIZE ESTIMATION 31 2.2.1 BOTTOM-UP APPROACH 31 2.2.1.1 Approach 1: Company revenue estimation approach 31 2.2.1.2 Approach 2: Presentations of companies and primary interviews 32 2.2.1.3 Approach 3: Primary interviews 32 2.2.1.4 Growth forecast 32 2.2.1.5 CAGR projections 33 2.2.2 TOP-DOWN APPROACH 33 2.3 MARKET BREAKDOWN & DATA TRIANGULATION 34 2.4 RESEARCH ASSUMPTIONS 36 2.4.1 STUDY-RELATED ASSUMPTIONS 36 2.4.2 PARAMETRIC ASSUMPTIONS 36 2.4.3 GROWTH RATE ASSUMPTIONS 36 2.5 RISK ASSESSMENT 37 2.6 RESEARCH LIMITATIONS 37 3 EXECUTIVE SUMMARY 38   4 PREMIUM INSIGHTS 42 4.1 LATAM ADVANCED WOUND CARE MARKET OVERVIEW 42 4.2 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY END USER AND WOUND TYPE (2024) 43 4.3 LATAM ADVANCED WOUND CARE MARKET, BY KEY COUNTRY 44 4.4 COUNTRY MIX: LATAM ADVANCED WOUND CARE MARKET, 2024 45 5 MARKET OVERVIEW 46 5.1 INTRODUCTION 46 5.2 MARKET DYNAMICS 46 5.2.1 DRIVERS 47 5.2.1.1 Increasing incidence of chronic conditions impairing wound healing 47 5.2.1.1.1 Expansion of geriatric population and emergence of age-associated syndromes 47 5.2.1.1.2 Rising incidence of diabetes 47 5.2.1.1.3 Increasing cases of obesity 48 5.2.1.2 Growing number of burn injuries 49 5.2.1.3 Rising trauma cases and road accidents 49 5.2.2 RESTRAINTS 49 5.2.2.1 High cost of advanced wound care products 49 5.2.2.2 Risks associated with advanced wound care products 50 5.2.3 OPPORTUNITIES 51 5.2.3.1 Expansion of healthcare infrastructure and uptake of advanced technologies 51 5.2.3.2 Universal health coverage 51 5.2.4 CHALLENGES 51 5.2.4.1 Shortage of skilled healthcare professionals 51 5.2.4.2 Complications associated with delayed diagnosis and limited awareness 52 5.3 PRICING ANALYSIS 52 5.3.1 INDICATIVE PRICING OF KEY PLAYERS, BY APPLICATION (2025) 52 5.3.2 AVERAGE SELLING PRICE TREND, BY COUNTRY, 2023–2025 53 5.3.3 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025 54 5.4 VALUE CHAIN ANALYSIS 54 5.4.1 RESEARCH & DEVELOPMENT (R&D) 54 5.4.2 MANUFACTURING 54 5.4.3 DISTRIBUTION AND MARKETING & SALES 54 5.4.4 POST-SALES SERVICES 55 5.5 SUPPLY CHAIN ANALYSIS 55 5.5.1 PROMINENT COMPANIES 55 5.5.2 SMALL & MEDIUM-SIZED ENTERPRISES 55 5.5.3 END USERS 56 5.6 ECOSYSTEM ANALYSIS 56 5.7 PORTER’S FIVE FORCES ANALYSIS 57 5.7.1 THREAT OF NEW ENTRANTS 59 5.7.2 THREAT OF SUBSTITUTES 59 5.7.3 BARGAINING POWER OF SUPPLIERS 59 5.7.4 BARGAINING POWER OF BUYERS 59 5.7.5 INTENSITY OF COMPETITIVE RIVALRY 59 5.8 REGULATORY ANALYSIS 60 5.8.1 REGULATORY LANDSCAPE 60 5.8.1.1 Brazil 60 5.8.1.2 Mexico 60 5.8.1.3 Colombia 60 5.8.1.4 Argentina 61 5.8.1.5 Peru 61 5.8.1.6 Chile 62 5.8.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 5.9 TECHNOLOGY ANALYSIS 63 5.9.1 KEY TECHNOLOGIES 63 5.9.1.1 Portable Negative Pressure Wound Therapy (NPWT) devices 63 5.9.2 ADJACENT TECHNOLOGIES 64 5.9.2.1 Telemedicine for wound care 64 5.9.3 COMPLEMENTARY TECHNOLOGIES 64 5.9.3.1 Antimicrobial wound dressings 64 5.10 TRADE ANALYSIS 65 5.10.1 TRADE ANALYSIS FOR ADHESIVE DRESSINGS 65 5.11 PATENT ANALYSIS 66 5.12 KEY CONFERENCES & EVENTS, 2025 67 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67 5.14 KEY STAKEHOLDERS & BUYING CRITERIA 68 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 68 5.14.2 BUYING CRITERIA 69 5.15 IMPACT OF AI/GENERATIVE AI ON LATAM ADVANCED WOUND CARE MARKET 69 5.15.1 INTRODUCTION 69 5.15.2 POTENTIAL OF AI IN ADVANCED WOUND CARE 69 5.15.3 AI USE CASES 70 5.15.4 FUTURE OF GENERATIVE AI ON ADVANCED WOUND CARE 71 5.16 INVESTMENT & FUNDING SCENARIO 71 5.17 CASE STUDY ANALYSIS 72 5.17.1 CASE STUDY 1: EFFECTIVE WOUND MANAGEMENT WITH BIATAIN SILICONE 72 5.17.2 CASE STUDY 2: ENHANCING WOUND CARE WITH MEPILEX UP 72 5.17.3 CASE STUDY 3: HYDROCOLL HYDROCOLLOID DRESSING SUPPORTS WOUND HEALING 73 6 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT 74 6.1 INTRODUCTION 75 6.2 FOAM DRESSINGS 75 6.2.1 SILICON DRESSINGS 77 6.2.1.1 Bordered silicon dressings 78 6.2.1.1.1 Gentle adhesive qualities to fuel uptake 78 6.2.1.2 Non-bordered silicon dressings 79 6.2.1.2.1 Highly absorbent foam core to boost adoption 79 6.2.2 NON-SILICON DRESSINGS 80 6.2.2.1 High comfort and conformability to boost market 80 6.2.3 XEROFORM DRESSINGS 81 6.2.3.1 Provision of bacteriostatic properties to fuel greater demand 81 6.2.4 HYDROCOLLOID DRESSINGS 82 6.2.4.1 Increased functionality and enhanced collagen synthesis to drive market 82 6.2.5 FILM DRESSINGS 83 6.2.5.1 Transparent and elastic properties to fuel uptake 83 6.2.6 ALGINATE DRESSINGS 84 6.2.6.1 High incidence of burn injuries to boost market 84 6.2.7 GELLING DRESSINGS 86 6.2.7.1 Effective management of moderate to heavy exuding wounds to support market growth 86 6.2.8 COLLAGEN DRESSINGS 87 6.2.8.1 Inflammatory control and facilitation of protein synthesis to drive market 87 6.2.9 OTHER ADVANCED DRESSINGS 88 7 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE 90 7.1 INTRODUCTION 91 7.2 CHRONIC WOUNDS 92 7.2.1 DIABETIC FOOT ULCERS 93 7.2.1.1 Increasing prevalence of diabetes to drive market 93 7.2.2 PRESSURE ULCERS 95 7.2.2.1 Rising geriatric population and subsequent increase in comorbidities to fuel market 95 7.2.3 VENOUS LEG ULCERS 96 7.2.3.1 Increasing prevalence of obesity to support market growth 96 7.2.4 OTHER CHRONIC WOUNDS 97 7.3 ACUTE WOUNDS 98 7.3.1 SURGICAL & TRAUMATIC WOUNDS 99 7.3.1.1 Increasing volume of surgical procedures due to trauma & road accidents to fuel market 99   7.3.2 BURNS 100 7.3.2.1 High incidence of burn injuries to support market growth 100 8 LATAM ADVANCED WOUND CARE MARKET, BY END USER 102 8.1 INTRODUCTION 103 8.2 HOSPITALS & CLINICS 103 8.2.1 RISING INCIDENCE OF HAIS TO DRIVE MARKET 103 8.3 AMBULATORY SURGERY CENTERS 105 8.3.1 PROVISION OF SPECIALIZED WOUND CARE SERVICES TO PROPEL MARKET 105 8.4 HOME CARE SETTINGS 106 8.4.1 LOW COSTS AND CONVENIENCE TO BOOST DEMAND 106 8.5 OTHER END USERS 107 9 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY 109 9.1 INTRODUCTION 110 9.2 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 110 9.2.1 BRAZIL 111 9.2.1.1 Large healthcare sector to fuel demand 111 9.2.2 MEXICO 116 9.2.2.1 Rising incidence of diabetes and chronic wounds to propel market 116 9.2.3 COLOMBIA 120 9.2.3.1 Increasing incidence of venous ulcers to boost demand 120 9.2.4 ARGENTINA 124 9.2.4.1 Increasing cases of burn injuries and trauma cases to support market growth 124 9.2.5 PERU 128 9.2.5.1 Growing requirement for efficient wound healing management due to shortage of skilled professionals to fuel market 128 9.2.6 CHILE 132 9.2.6.1 Improvements in healthcare infrastructure to support market growth 132 9.2.7 REST OF LATIN AMERICA 135 10 COMPETITIVE LANDSCAPE 139 10.1 OVERVIEW 139 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 139 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET 139 10.3 REVENUE ANALYSIS, 2021−2023 140 10.4 MARKET SHARE ANALYSIS, 2024 141 10.5 COMPANY VALUATION AND FINANCIAL METRICS 144 10.5.1 COMPANY VALUATION 144 10.5.2 FINANCIAL METRICS 144   10.6 BRAND/PRODUCT COMPARISON 145 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 145 10.7.1 STARS 146 10.7.2 EMERGING LEADERS 146 10.7.3 PERVASIVE PLAYERS 146 10.7.4 PARTICIPANTS 146 10.7.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 148 10.7.5.1 Company footprint 148 10.7.5.2 Region footprint 149 10.7.5.3 Product footprint 150 10.7.5.4 Wound type footprint 151 10.7.5.5 End-user footprint 152 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 153 10.8.1 PROGRESSIVE COMPANIES 153 10.8.2 RESPONSIVE COMPANIES 153 10.8.3 DYNAMIC COMPANIES 153 10.8.4 STARTING BLOCKS 153 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 154 10.8.5.1 Detailed list of key startups/SMEs 154 10.8.5.2 Competitive benchmarking of key startups/SMEs 155 10.9 COMPETITIVE SCENARIO 156 10.9.1 PRODUCT LAUNCHES 156 10.9.2 DEALS 156 10.9.3 EXPANSIONS 157 10.9.4 OTHER DEVELOPMENTS 158 11 COMPANY PROFILES 159 11.1 KEY PLAYERS 159 11.1.1 SOLVENTUM 159 11.1.1.1 Business overview 159 11.1.1.2 Products offered 160 11.1.1.3 Recent developments 161 11.1.1.3.1 Other developments 161 11.1.1.4 MnM view 162 11.1.1.4.1 Right to win 162 11.1.1.4.2 Strategic choices 162 11.1.1.4.3 Weaknesses & competitive threats 162 11.1.2 MÖLNLYCKE AB 163 11.1.2.1 Business overview 163 11.1.2.2 Products offered 165 11.1.2.3 Recent developments 166 11.1.2.3.1 Deals 166 11.1.2.4 MnM view 166 11.1.2.4.1 Right to win 166 11.1.2.4.2 Strategic choices 166 11.1.2.4.3 Weaknesses & competitive threats 166 11.1.3 COLOPLAST GROUP 167 11.1.3.1 Business overview 167 11.1.3.2 Products offered 168 11.1.3.3 Recent developments 169 11.1.3.3.1 Deals 169 11.1.3.4 MnM view 169 11.1.3.4.1 Right to win 169 11.1.3.4.2 Strategic choices 169 11.1.3.4.3 Weaknesses & competitive threats 169 11.1.4 SMITH+NEPHEW 170 11.1.4.1 Business overview 170 11.1.4.2 Products offered 171 11.1.4.3 Recent developments 172 11.1.4.3.1 Deals 172 11.1.4.3.2 Expansions 173 11.1.4.3.3 Other developments 173 11.1.4.4 MnM view 174 11.1.4.4.1 Right to win 174 11.1.4.4.2 Strategic choices 174 11.1.4.4.3 Weaknesses & competitive threats 174 11.1.5 CONVATEC GROUP PLC 175 11.1.5.1 Business overview 175 11.1.5.2 Products offered 176 11.1.5.3 Recent developments 177 11.1.5.3.1 Product launches/approvals/enhancements 177 11.1.5.3.2 Deals 177 11.1.5.4 MnM view 178 11.1.5.4.1 Right to win 178 11.1.5.4.2 Strategic choices 178 11.1.5.4.3 Weaknesses & competitive threats 178 11.1.6 CARDINAL HEALTH 179 11.1.6.1 Business overview 179 11.1.6.2 Products offered 180 11.1.6.3 Recent developments 181 11.1.6.3.1 Expansions 181 11.1.7 B. BRAUN SE 183 11.1.7.1 Business overview 183 11.1.7.2 Products offered 184 11.1.7.3 Recent developments 185 11.1.7.3.1 Deals 185 11.1.7.3.2 Expansions 185 11.1.8 ESSITY AKTIEBOLAG 186 11.1.8.1 Business overview 186 11.1.8.2 Products offered 187 11.1.8.3 Recent developments 188 11.1.8.3.1 Deals 188 11.1.8.3.2 Expansions 188 11.1.9 PAUL HARTMANN AG 189 11.1.9.1 Business overview 189 11.1.9.2 Products offered 190 11.1.9.3 Recent developments 191 11.1.9.3.1 Deals 191 11.1.10 INTEGRA LIFESCIENCES CORPORATION 192 11.1.10.1 Business overview 192 11.1.10.2 Products offered 193 11.1.10.3 Recent developments 194 11.1.10.3.1 Deals 194 11.1.10.3.2 Expansions 194 11.1.11 MATIV HOLDINGS, INC. 195 11.1.11.1 Business overview 195 11.1.11.2 Products offered 196 11.1.11.3 Recent developments 197 11.1.11.3.1 Deals 197 11.1.12 OWENS & MINOR 198 11.1.12.1 Business overview 198 11.1.12.2 Products offered 199 11.1.12.3 Recent developments 200 11.1.12.3.1 Deals 200 11.1.13 AVERY DENNISON CORPORATION 202 11.1.13.1 Business overview 202 11.1.13.2 Products offered 203 11.1.13.3 Recent developments 204 11.1.13.3.1 Deals 204 11.1.13.3.2 Expansions 204 11.2 OTHER PLAYERS 205 11.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 205 11.2.2 MEDLINE INDUSTRIES, LP 206 11.2.3 FERRIS MFG. CORP. 207 11.2.4 TRIAGE MEDTECH 207 11.2.5 MISSNER & MISSNER LTDA 208 11.2.6 DEROYAL INDUSTRIES, INC. 209 11.2.7 HOLLISTER INCORPORATED 210 11.2.8 WINNER MEDICAL CO., LTD. 211 11.2.9 URGO MEDICAL 212 11.2.10 BAIHE MEDICAL 212 11.2.11 CREMER S.A. 213 11.2.12 ADVANCIS (UK) 214 12 APPENDIX 215 12.1 DISCUSSION GUIDE 215 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 218 12.3 CUSTOMIZATION OPTIONS 220 12.4 RELATED REPORTS 220 12.5 AUTHOR DETAILS 221
圖表清單 List of Tables & Figures
TABLE 1 LATAM ADVANCED WOUND CARE MARKET: INCLUSIONS & EXCLUSIONS 23 TABLE 2 LATAM ADVANCED WOUND CARE WOUND CARE MARKET: RISK ASSESSMENT 37 TABLE 3 PEOPLE WITH DIABETES (20–79 YEARS), BY COUNTRY, 2021 VS. 2045 (IN THOUSANDS) 48 TABLE 4 PREVALENCE OF OVERWEIGHT ADULTS, BMI ≥ 25 KG/M² (AGE-STANDARDIZED ESTIMATE) (%); 18+ YEARS IN LATIN AMERICA, MALE & FEMALE 48 TABLE 5 AVERAGE TREATMENT COST FOR DIABETIC FOOT ULCERS 50 TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE PRODUCTS 50 TABLE 7 INDICATIVE PRICE OF KEY PLAYERS FOR WOUND TYPE IN 2025 (USD) 53 TABLE 8 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY COUNTRY, 2023–2025 53 TABLE 9 AVERAGE SELLING PRICE TREND, BY PRODUCT, 2023–2025 54 TABLE 10 LATAM ADVANCED WOUND CARE MARKET: ROLE IN ECOSYSTEM 57 TABLE 11 LATAM ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 58 TABLE 12 LATIN AMERICA: LIST OF KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 62 TABLE 13 IMPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2020–2024 (USD MILLION) 65 TABLE 14 EXPORT DATA FOR ADHESIVE DRESSINGS, BY COUNTRY, 2020–2024 (USD MILLION) 65 TABLE 15 LATAM ADVANCED WOUND CARE MARKET: KEY CONFERENCES & EVENTS, 2025 67 TABLE 16 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER (%) 68 TABLE 17 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS, BY RANK 69 TABLE 18 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 75 TABLE 19 KEY PRODUCTS OFFERED IN FOAM DRESSINGS MARKET 76 TABLE 20 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 76 TABLE 21 LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 77 TABLE 22 LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 77 TABLE 23 LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 78 TABLE 24 LATAM ADVANCED WOUND CARE MARKET FOR BORDERED DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 79 TABLE 25 LATAM ADVANCED WOUND CARE MARKET FOR NON-BORDERED SILICON DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 80 TABLE 26 LATAM ADVANCED WOUND CARE MARKET FOR NON-SILICON DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 81 TABLE 27 KEY PRODUCTS OFFERED IN XEROFORM DRESSINGS MARKET 81 TABLE 28 LATAM ADVANCED WOUND CARE MARKET FOR XEROFORM DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 82 TABLE 29 KEY PRODUCTS OFFERED IN HYDROCOLLOID DRESSINGS MARKET 83 TABLE 30 LATAM ADVANCED WOUND CARE MARKET FOR HYDROCOLLOID DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 83 TABLE 31 KEY PRODUCTS OFFERED IN FILM DRESSINGS MARKET 84 TABLE 32 LATAM ADVANCED WOUND CARE MARKET FOR FILM DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 84 TABLE 33 KEY PRODUCTS OFFERED IN ALGINATE DRESSINGS MARKET 85 TABLE 34 LATAM ADVANCED WOUND CARE MARKET FOR ALGINATE DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 85 TABLE 35 KEY PRODUCTS OFFERED IN GELLING DRESSINGS MARKET 86 TABLE 36 LATAM ADVANCED WOUND CARE MARKET FOR GELLING DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 86 TABLE 37 KEY PRODUCTS OFFERED IN COLLAGEN DRESSINGS MARKET 87 TABLE 38 LATAM ADVANCED WOUND CARE MARKET FOR COLLAGEN DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 88 TABLE 39 OTHER ADVANCED DRESSINGS OFFERED 89 TABLE 40 LATAM ADVANCED WOUND CARE MARKET FOR OTHER ADVANCED DRESSINGS, BY COUNTRY, 2022–2030 (USD MILLION) 89 TABLE 41 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 91 TABLE 42 CHRONIC WOUNDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 91 TABLE 43 ACUTE WOUNDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 92 TABLE 44 CHRONIC WOUNDS MARKET, BY TYPE, 2022–2030 (USD MILLION) 93 TABLE 45 PREVALENCE OF DIABETES IN LATIN AMERICA, BY COUNTRY (2021) 94 TABLE 46 CHRONIC WOUNDS MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2022–2030 (USD MILLION) 94 TABLE 47 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS (THOUSANDS) 95 TABLE 48 CHRONIC WOUNDS MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2022–2030 (USD MILLION) 96 TABLE 49 CHRONIC WOUNDS MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2022–2030 (USD MILLION) 97 TABLE 50 OTHER CHRONIC WOUNDS MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 98 TABLE 51 ACUTE WOUNDS MARKET, BY TYPE, 2022–2030 (USD MILLION) 98 TABLE 52 ACUTE WOUNDS MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2022–2030 (USD MILLION) 100 TABLE 53 ACUTE WOUNDS MARKET FOR BURNS, BY COUNTRY, 2022–2030 (USD MILLION) 101 TABLE 54 LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 103 TABLE 55 HOSPITALS PER CAPITA, BY COUNTRY (2025) 104 TABLE 56 LATAM ADVANCED WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2022–2030 (USD MILLION) 104 TABLE 57 LATAM ADVANCED WOUND CARE MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2022–2030 (USD MILLION) 105 TABLE 58 LATAM ADVANCED WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2022–2030 (USD MILLION) 107 TABLE 59 LATAM ADVANCED WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY, 2022–2030 (USD MILLION) 108 TABLE 60 LATIN AMERICA: MACROECONOMIC INDICATORS 110 TABLE 61 LATAM ADVANCED WOUND CARE MARKET, BY COUNTRY, 2022–2030 (USD MILLION) 111 TABLE 62 BRAZIL: MACROECONOMIC INDICATORS 112 TABLE 63 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 114 TABLE 64 BRAZIL: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 114 TABLE 65 BRAZIL: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 115 TABLE 66 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 115 TABLE 67 BRAZIL: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 115 TABLE 68 BRAZIL: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 116 TABLE 69 BRAZIL: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 116 TABLE 70 MEXICO: MACROECONOMIC INDICATORS 117 TABLE 71 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 118 TABLE 72 MEXICO: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 118 TABLE 73 MEXICO: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 119 TABLE 74 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 119 TABLE 75 MEXICO: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 119 TABLE 76 MEXICO: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 120 TABLE 77 MEXICO: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 120 TABLE 78 COLOMBIA: MACROECONOMIC INDICATORS 121 TABLE 79 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 122 TABLE 80 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 122 TABLE 81 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 123 TABLE 82 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 123 TABLE 83 COLOMBIA: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 123 TABLE 84 COLOMBIA: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 124 TABLE 85 COLOMBIA: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 124 TABLE 86 ARGENTINA: MACROECONOMIC INDICATORS 125 TABLE 87 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 126 TABLE 88 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 126 TABLE 89 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 127 TABLE 90 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 127 TABLE 91 ARGENTINA: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 127 TABLE 92 ARGENTINA: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 128 TABLE 93 ARGENTINA: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 128 TABLE 94 PERU: MACROECONOMIC INDICATORS 129 TABLE 95 PERU: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 129 TABLE 96 PERU: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 130 TABLE 97 PERU: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 130 TABLE 98 PERU: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 130 TABLE 99 PERU: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 131 TABLE 100 PERU: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 131 TABLE 101 PERU: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 131 TABLE 102 CHILE: MACROECONOMIC INDICATORS 132 TABLE 103 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 133 TABLE 104 CHILE: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 133 TABLE 105 CHILE: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 134 TABLE 106 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 134 TABLE 107 CHILE: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 134 TABLE 108 CHILE: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 135 TABLE 109 CHILE: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 135 TABLE 110 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 136 TABLE 111 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET FOR FOAM DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 136 TABLE 112 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET FOR SILICON DRESSINGS, BY TYPE, 2022–2030 (USD MILLION) 137 TABLE 113 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 137 TABLE 114 REST OF LATIN AMERICA: CHRONIC WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 137 TABLE 115 REST OF LATIN AMERICA: ACUTE WOUNDS MARKET, BY WOUND TYPE, 2022–2030 (USD MILLION) 138 TABLE 116 REST OF LATIN AMERICA: LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2022–2030 (USD MILLION) 138 TABLE 117 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2022–2025 139 TABLE 118 LATAM ADVANCED WOUND CARE MARKET: DEGREE OF COMPETITION 142 TABLE 119 LATAM ADVANCED WOUND CARE MARKET: REGION FOOTPRINT 149 TABLE 120 LATAM ADVANCED WOUND CARE MARKET: PRODUCT FOOTPRINT 150 TABLE 121 LATAM ADVANCED WOUND CARE MARKET: WOUND TYPE FOOTPRINT 151 TABLE 122 LATAM ADVANCED WOUND CARE MARKET: END-USER FOOTPRINT 152 TABLE 123 LATAM ADVANCED WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 154 TABLE 124 LATAM ADVANCED WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 155 TABLE 125 LATAM ADVANCED WOUND CARE MARKET: PRODUCT LAUNCHES, JANUARY 2022–FEBRUARY 2025 156 TABLE 126 LATAM ADVANCED WOUND CARE MARKET: DEALS, JANUARY 2022–FEBRUARY 2025 156 TABLE 127 LATAM ADVANCED WOUND CARE MARKET: EXPANSIONS, JANUARY 2022–FEBRUARY 2025 157 TABLE 128 LATAM ADVANCED WOUND CARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022−FEBRUARY 2025 158 TABLE 129 SOLVENTUM: COMPANY OVERVIEW 159 TABLE 130 SOLVENTUM: PRODUCTS OFFERED 160 TABLE 131 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2021–FEBRUARY 2025 161 TABLE 132 MÖLNLYCKE AB: COMPANY OVERVIEW 163 TABLE 133 MÖLNLYCKE AB: PRODUCTS OFFERED 165 TABLE 134 MÖLNLYCKE AB: DEALS, JANUARY 2021–FEBRUARY 2025 166 TABLE 135 COLOPLAST GROUP: COMPANY OVERVIEW 167 TABLE 136 COLOPLAST GROUP: PRODUCTS OFFERED 168 TABLE 137 COLOPLAST GROUP: DEALS, JANUARY 2021–FEBRUARY 2025 169 TABLE 138 SMITH+NEPHEW: COMPANY OVERVIEW 170 TABLE 139 SMITH+NEPHEW: PRODUCTS OFFERED 171 TABLE 140 SMITH+NEPHEW: DEALS, JANUARY 2021–FEBRUARY 2025 172 TABLE 141 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 173 TABLE 142 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2021–FEBRUARY 2025 173 TABLE 143 CONVATEC GROUP PLC: COMPANY OVERVIEW 175 TABLE 144 CONVATEC GROUP PLC: PRODUCTS OFFERED 176 TABLE 145 CONVATEC GROUP PLC: PRODUCT LAUNCHES/APPROVALS/ENHANCEMENTS, JANUARY 2021–FEBRUARY 2025 177 TABLE 146 CONVATEC GROUP PLC: DEALS, JANUARY 2021–FEBRUARY 2025 177 TABLE 147 CARDINAL HEALTH: COMPANY OVERVIEW 179 TABLE 148 CARDINAL HEALTH: PRODUCTS OFFERED 180 TABLE 149 CARDINAL HEALTH: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 181 TABLE 150 B. BRAUN SE: COMPANY OVERVIEW 183 TABLE 151 B. BRAUN SE: PRODUCTS OFFERED 184 TABLE 152 B. BRAUN SE: DEALS, JANUARY 2021–FEBRUARY 2025 185 TABLE 153 B. BRAUN SE: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 185 TABLE 154 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 186 TABLE 155 ESSITY AKTIEBOLAG: PRODUCTS OFFERED 187 TABLE 156 ESSITY AKTIEBOLAG: DEALS, JANUARY 2021–FEBRUARY 2025 188 TABLE 157 ESSITY AKTIEBOLAG: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 188 TABLE 158 PAUL HARTMANN AG: COMPANY OVERVIEW 189 TABLE 159 PAUL HARTMANN AG: PRODUCTS OFFERED 190 TABLE 160 PAUL HARTMANN AG: DEALS, JANUARY 2021–FEBRUARY 2025 191 TABLE 161 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 192 TABLE 162 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 193 TABLE 163 INTEGRA LIFESCIENCES: DEALS JANUARY 2021–FEBRUARY 2025 194 TABLE 164 INTEGRA LIFESCIENCES CORPORATION: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 194 TABLE 165 MATIV HOLDINGS, INC.: COMPANY OVERVIEW 195 TABLE 166 MATIV HOLDINGS, INC.: PRODUCTS OFFERED 196 TABLE 167 MATIV HOLDINGS, INC.: DEALS, JANUARY 2021–FEBRUARY 2025 197 TABLE 168 OWENS & MINOR: COMPANY OVERVIEW 198 TABLE 169 OWENS & MINOR: PRODUCTS OFFERED 199 TABLE 170 OWENS & MINOR: DEALS, JANUARY 2021–FEBRUARY 2025 200 TABLE 171 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 202 TABLE 172 AVERY DENNISON CORPORATION: PRODUCTS OFFERED 203 TABLE 173 AVERY DENNISON CORPORATION: DEALS, JANUARY 2021–FEBRUARY 2025 204 TABLE 174 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2021–FEBRUARY 2025 204 TABLE 175 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 205 TABLE 176 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 206 TABLE 177 FERRIS MFG. CORP.: COMPANY OVERVIEW 207 TABLE 178 TRIAGE MEDTECH: COMPANY OVERVIEW 207 TABLE 179 MISSNER & MISSNER LTDA: COMPANY OVERVIEW 208 TABLE 180 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 209 TABLE 181 HOLLISTER INCORPORATED: COMPANY OVERVIEW 210 TABLE 182 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 211 TABLE 183 URGO MEDICA: COMPANY OVERVIEW 212 TABLE 184 BAIHE MEDICAL: COMPANY OVERVIEW 212 TABLE 185 CREMER S.A.: COMPANY OVERVIEW 213 TABLE 186 ADVANCIS (UK): COMPANY OVERVIEW 214 _ FIGURE 1 LATAM ADVANCED WOUND CARE MARKET: RESEARCH DESIGN 25 FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND COUNTRIES 30 FIGURE 3 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 31 FIGURE 4 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 33 FIGURE 5 LATAM ADVANCED WOUND CARE MARKET: TOP-DOWN APPROACH 33 FIGURE 6 DATA TRIANGULATION METHODOLOGY 35 FIGURE 7 LATAM ADVANCED WOUND CARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 38 FIGURE 8 LATAM ADVANCED WOUND CARE MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION) 39 FIGURE 9 LATAM ADVANCED WOUND CARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 40 FIGURE 10 GEOGRAPHIC SNAPSHOT OF LATAM ADVANCED WOUND CARE MARKET 41 FIGURE 11 RISING INCIDENCE OF CHRONIC CONDITIONS AND AGE-ASSOCIATED SYNDROMES TO FUEL MARKET 42 FIGURE 12 HOSPITALS & CLINICS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 43 FIGURE 13 MEXICO TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 44 FIGURE 14 BRAZIL ACCOUNTED FOR LARGEST MARKET SHARE IN 2024 45 FIGURE 15 LATAM ADVANCED WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 46 FIGURE 16 LATAM ADVANCED WOUND CARE MARKET: VALUE CHAIN ANALYSIS 55 FIGURE 17 LATAM ADVANCED WOUND CARE MARKET: SUPPLY CHAIN ANALYSIS 56 FIGURE 18 LATAM ADVANCED WOUND CARE MARKET: ECOSYSTEM ANALYSIS 57 FIGURE 19 LATAM ADVANCED WOUND CARE MARKET: PORTER’S FIVE FORCES ANALYSIS 58 FIGURE 20 LATAM ADVANCED WOUND CARE MARKET: PATENT ANALYSIS, JANUARY 2015–MARCH 2024 66 FIGURE 21 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 67 FIGURE 22 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY END USER 68 FIGURE 23 KEY BUYING CRITERIA FOR ADVANCED WOUND CARE PRODUCTS, BY END USER 69 FIGURE 24 INVESTMENT & FUNDING SCENARIO, 2020−2025 71 FIGURE 25 BRAZIL: LATAM ADVANCED WOUND CARE MARKET SNAPSHOT 113 FIGURE 26 REVENUE ANALYSIS OF KEY PLAYERS, 2021−2023 (USD MILLION) 141 FIGURE 27 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 142 FIGURE 28 RANKING OF KEY PLAYERS IN LATAM ADVANCED WOUND CARE MARKET, 2024 143 FIGURE 29 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS, 2025 144 FIGURE 30 FINANCIAL METRICS, 2025 144 FIGURE 31 LATAM ADVANCED WOUND CARE MARKET: BRAND/PRODUCT COMPARISON 145 FIGURE 32 LATAM ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 147 FIGURE 33 LATAM ADVANCED WOUND CARE MARKET: COMPANY FOOTPRINT 148 FIGURE 34 LATAM ADVANCED WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 154 FIGURE 35 SOLVENTUM: COMPANY SNAPSHOT (2024) 160 FIGURE 36 MÖLNLYCKE AB: COMPANY SNAPSHOT (2023) 164 FIGURE 37 COLOPLAST GROUP: COMPANY SNAPSHOT (2024) 168 FIGURE 38 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 171 FIGURE 39 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2023) 176 FIGURE 40 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 180 FIGURE 41 B. BRAUN SE: COMPANY SNAPSHOT (2023) 184 FIGURE 42 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024) 187 FIGURE 43 PAUL HARTMANN AG: COMPANY SNAPSHOT (2023) 190 FIGURE 44 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2023) 193 FIGURE 45 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 196 FIGURE 46 OWENS & MINOR: COMPANY SNAPSHOT (2024) 199 FIGURE 47 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 203

同分類最新報告（醫療器材）

查看醫療器材全部報告 →

量子訊息有限公司為 MarketsandMarkets 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們